Use of sodium–glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry-Reference-Cited by-同舟云学术

Use of sodium–glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry

Published:2021-03-02 Issue:6 Volume:23 Page:1012-1022
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Becher Peter M.¹²³,Schrage Benedikt¹²³,Ferrannini Giulia¹,Benson Lina¹,Butler Javed⁴,Carrero Juan Jesus⁵,Cosentino Francesco¹⁶,Dahlström Ulf⁷,Mellbin Linda¹⁶,Rosano Giuseppe M.C.⁸,Sinagra Gianfranco⁹,Stolfo Davide¹⁹,Lund Lars H.¹⁶,Savarese Gianluigi¹⁶^ORCID

Affiliation:

1. Division of Cardiology, Department of Medicine Karolinska Institutet Stockholm Sweden

2. Department of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany

3. Germany German Center of Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck Hamburg Germany

4. Department of Medicine University of Mississippi Jackson MS USA

5. Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

6. Heart and Vascular Theme Karolinska University Hospital Stockholm Sweden

7. Department of Cardiology and Department of Health, Medicine and Caring Sciences Linkoping University Linkoping Sweden

8. Department of Medical Sciences IRCCS San Raffaele Rome Italy

9. Cardiovascular Department Azienda Sanitaria Giuliano Isontina (ASUGI), University of Trieste Trieste Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2131

Reference31 articles.

1. Global Public Health Burden of Heart Failure

2. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

3. Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial

4. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing of sodium–glucose cotransporter 2 inhibitor initiation and post‐discharge outcomes in acute heart failure with diabetes: A population‐based cohort study;European Journal of Heart Failure;2024-09-12

2. Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry;European Journal of Heart Failure;2024-09-10

3. Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction;Journal of Clinical Medicine;2024-08-30

4. Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction;European Journal of Preventive Cardiology;2024-06-03

5. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC;European Journal of Heart Failure;2024-05-22